73
Value versus growth: Some statistical evidence Bruce Greenwald & Tano Santos Columbia Business School Columbia University

Gmo the value vs growth dilemma

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Gmo the value vs growth dilemma

Value versus growth: Some

statistical evidence

Bruce Greenwald & Tano Santos

Columbia Business School

Columbia University

Page 2: Gmo the value vs growth dilemma

Introduction

• We focus in this course on the fundamental value

of the investment at the expense of any other

consideration.

• In particular: Value investing is about levels and

the comparison between value and the market

price.

• Specifically, we can classify the approaches to

investing along the following dimensions.

Page 3: Gmo the value vs growth dilemma

Approaches to investing

3

Approaches to investment

Efficient Markets

•Diversification

•Asset Allocation

•Cost minimization

Page 4: Gmo the value vs growth dilemma

Approaches to investing

4

Approaches to investment

Efficient MarketsShort term

•Diversification

•Asset Allocation

•Cost minimization

FundamentalValue

Changes

•Current Price vs. forecast change

•Micro

•Macro

Technical

•Value strategies

•Momentum

•Price/Volume patterns

Page 5: Gmo the value vs growth dilemma

Approaches to investing

5

Approaches to investment

Efficient MarketsShort termLong term

FundamentalValue

Levels

•Diversification

•Asset Allocation

•Cost minimization

•Mkt. price

vs. value

FundamentalValue

Changes

•Current Price vs. forecast change

•Micro

•Macro

Technical

•Value strategies

•Momentum

•Price/Volume patterns

Page 6: Gmo the value vs growth dilemma

Introduction

• The essential value investing principles are:

1. Identification of the firms whose value is reliably calculable

by you (circle of competence.)

2. Among these firms, invest in those whose market price

(equity plus debt) is below your calculated value by an

appropriate margin of safety (1/3 to 1/2).

• Thus, value investing emphasizes specialization and it

focuses on specific names and emphasizes prudence

to guarantee the protection of principal.

• Understanding the principles above is the purpose of

this course.

6

Page 7: Gmo the value vs growth dilemma

Introduction

• Today though we ask the following question:

- Are there superior returns associated with investing in

companies which are “cheap” relative to some measure of

fundamentals?

• For instance, if we classify firms according to their

book-to-market, do firms which have high book-to-

market (BE/ME) yield on average higher returns than

do firms with low BE/ME?

• To preview the answer:

- Value (high BE/ME) stocks command higher average

returns though they are not riskier.

7

Page 8: Gmo the value vs growth dilemma

Outline

• In what follows we divide the presentation in two

parts:

1. The cross section of stock returns:

a) Value strategies

b) Momentum

c) Long term reversal

d) Industry

2. The market portfolio

• Throughout it is important to remember that none

of this is what we refer to as value investing, which is

the application of simple principles to the analysis of

individual names.8

Page 9: Gmo the value vs growth dilemma

Outline

• In what follows we divide the presentation in two

parts:

1. The cross section of stock returns:

a) Value strategies

b) Momentum

c) Long term reversal

d) Industry

2. The market portfolio

• Throughout it is important to remember that none

of this is what we refer to as value investing, which is

the application of simple principles to the analysis of

individual names.9

Not today

Page 10: Gmo the value vs growth dilemma

THE CROSS SECTION

10

Page 11: Gmo the value vs growth dilemma

The value premium

• To assess whether value stocks, stocks with high

book-to-market, systematically yield high returns than

growth stocks we proceed as follows:

- We take all publicly traded stocks and sort them according

to BE/ME into ten portfolios

- Then we construct a “value strategy” by going long the

portfolio of stocks with high book-to-market which we fund

by shorting a portfolio of stocks with low book-to-market.

- The resulting portfolio is called the “High-Minus-Low”

portfolio, or HML.

- We then compute the monthly returns of this HML

portfolio since 1927.

11

Page 12: Gmo the value vs growth dilemma

Value sorts

12

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

June of year t

Page 13: Gmo the value vs growth dilemma

Value sorts

13

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

June of year t

Low book-to-market

High book-to-market

Page 14: Gmo the value vs growth dilemma

Value sorts

14

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

Growth portfolio

Value portfolio

June of year t

Page 15: Gmo the value vs growth dilemma

Value sorts

15

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

Stock 1

Stock 2

Stock 3

Stock 4

Stock 5

Stock 6

Stock 7

Stock 8

Stock 9

Stock 10

Growth portfolio

Value portfolio

Stock 3

Stock 2

Stock 7

Stock 9

Stock 8

Stock 1

Stock 10

Stock 4

Stock 6

Stock 5

Stock 3

Stock 2

Stock 7

Stock 9

Stock 8

Stock 1

Stock 10

Stock 4

Stock 6

Stock 5

Growth portfolio

Value portfolio

June of year t June of year t+1

Page 16: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

16

-60

-40

-20

0

20

40

60

19

27

19

29

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Mkt-RF

Annual market returns in excess of the one year treasury bill. 1927-2008. Source: Ken French database

Page 17: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

17

-60

-40

-20

0

20

40

60

19

27

19

29

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Mkt-RF

Great Depression – I (1929)

Great Depression – II (1937) Oil shock – I (1973)

Oil shock – II (1981)

End of tech. bubble (2000)

Great Recession - (2008)

Annual market returns in excess of the one year treasury bill. 1927-2008. Source: Ken French database

Page 18: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

18

-60

-40

-20

0

20

40

60

19

27

19

29

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Mkt-RF HML

Great Depression – I (1929)

Great Depression – II (1937) Oil shock – I (1973)

Oil shock – II (1981)

End of tech. bubble (2000)

Great Recession - (2008)

Annual market returns in excess of the one year treasury bill rate and the annual returns on a zero investment portfolio that is

long value stocks and short growth. 1927-2008. Source: Ken French database

Page 19: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

Growth Port. 2 Port. 3 Port. 4 Port. 5 Port. 6 Port. 7 Port. 8 Port. 9 Value

Avge.

BE/ME .20 .37 .49 .61 .72 .84 .97 1.14 1.40 2.21

Avge.

excess

return

(ann. %)

3.84 5.45 5.71 5.67 5.52 6.60 7.35 8.17 9.36 10.96

Average book-to-market, and excess returns for ten book-to-market sorted portfolios of all stocks in

Compustat; annualized; value weighted; 1963-01 to 2009-09; the portfolios are resorted at the end of June

and BE/ME is book equity at the last fiscal year end of the prior calendar year divided by ME at the end of

December of the prior year.

• So what are the returns of those ten sorted portfolios?

Page 20: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

• So in conclusion the value portfolio, the portfolio of

stocks with high book to market, earns, on average a

bit over 7% excess return over the growth portfolio.

• The evidence so far has exclusively focused on the

US.

• But, what about the international evidence?

• Unfortunately, the available data does not extend

back as far as it does in the US, but the overall picture

is identical:

20

Page 21: Gmo the value vs growth dilemma

Value vs. growth: international evidence

Market Value Growth

Japan 1.00 1.53 .64

UK 1.21 1.61 1.16

Germany 1.47 1.63 1.36

France 1.34 1.71 1.23

Spain 1.13 1.17 .99

Australia 1.33 1.65 1.15

Canada 1.13 1.15 .98

21

Monthly returns 1975-01 to 2007-12 (except for Canada where the sample starts in 1977-01) in percentages

Source: Ken French

Page 22: Gmo the value vs growth dilemma

The value premium: Is it risk?

• To reiterate: Value, the strategy of buying high BE/ME

stocks, yields superior returns to one that focuses on

growth or glamour stocks.

• Why? Two possible answers:

1. Risk - The higher average return of value portfolios simply

reflects a compensation for risk.

2. Mispricing - The higher average return of value portfolios

reflect a systematic undervaluation of value stocks relative

to growth

• Let’s try to shed some light on this issue.

22

Page 23: Gmo the value vs growth dilemma

The value premium: Is it risk?

• If the CAPM is a proper representation of risk then it

must be the case that value stocks have higher betas

than growth stocks.

• Do they? Does the value portfolio have a higher beta

than the growth portfolio? To answer this:

- Estimate βs by running a time series regression of the

excess returns of each of the ten portfolios on the market

excess return (the market model).

- Calculate the fitted CAPM average excess return for each

of the ten portfolios and compare them to the actual

average excess return in sample.

23

Page 24: Gmo the value vs growth dilemma

The value premium: Is it risk?

3

4

5

6

7

8

9

10

11

3 4 5 6 7 8 9 10 11

CA

PM

fit

ted

exce

ss r

etu

rns

Average excess returns

Average excess returns of ten book-to-market sorted portfolios against CAPM fitted excess

returns. 1963-1 – 2009-09. Source: Ken French database.

Page 25: Gmo the value vs growth dilemma

The value premium: Is it risk?

3

4

5

6

7

8

9

10

11

3 4 5 6 7 8 9 10 11

CA

PM

fit

ted

exce

ss r

etu

rns

Average excess returns

This is where the dots should be

if the CAPM betas captured risk

Average excess returns of ten book-to-market sorted portfolios against CAPM fitted excess

returns. 1963-1 – 2009-09. Source: Ken French database.

Page 26: Gmo the value vs growth dilemma

Is it risk? The CAPM and the value premium

3

4

5

6

7

8

9

10

11

3 4 5 6 7 8 9 10 11

CA

PM

fit

ted

exce

ss r

etu

rns

Average excess returns

Average excess returns of ten book-to-market sorted portfolios against CAPM fitted excess

returns. 1963-1 – 2009-09. Source: Ken French database.

Extreme Growth Extreme Value

Page 27: Gmo the value vs growth dilemma

The value premium: Is it risk?

3

4

5

6

7

8

9

10

11

3 4 5 6 7 8 9 10 11

CA

PM

fit

ted

exce

ss r

etu

rns

Average excess returns

Average excess returns of ten book-to-market sorted portfolios against CAPM fitted excess

returns. 1963-1 – 2009-09. Source: Ken French database.

Extreme growth yields less than

what is predicted by the CAPM

Extreme value yields more than

what is predicted by the CAPM

Page 28: Gmo the value vs growth dilemma

The value premium: Is it risk?

Growth Port. 2 Port. 3 Port. 4 Port. 5 Port. 6 Port. 7 Port. 8 Port. 9 Value

Avge.

BE/ME .20 .37 .49 .61 .72 .84 .97 1.14 1.40 2.21

Avge.

excess

return

(ann. %)

3.84 5.45 5.71 5.67 5.52 6.60 7.35 8.17 9.36 10.96

CAPM βs1.07 1.01 .98 .99 .91 .92 .86 .89 .92 1.05

CAPM

fitted excess

returns5.49 5.17 5.02 5.07 4.66 4.71 4.40 4.56 4.71 5.38

Average book-to-market, excess returns, CAPM betas and CAPM fitted excess returns for ten book-to-market sorted portfolios

of all stocks in Compustat; annualized; value weighted; 1963-01 to 2009-09; the portfolios are resorted at the end of June and

BE/ME is book equity at the last fiscal year end of the prior calendar year divided by ME at the end of December of the prior

year.

Page 29: Gmo the value vs growth dilemma

The value premium: Is it risk?

• The conclusion is striking: Value stocks have 7%

(annual) higher average returns than growth stocks

but the betas cannot explain any of it:

- Technically: Whereas average excess returns are an

increasing function of BE/ME betas have a flat relation with

returns.

- That is, the CAPM cannot explain the superior returns of

value strategies.

• But the CAPM may not be the right description of risk

- Are value stocks risky in that they do specially bad in bad

times relative to growth and thus the higher premium?

29

Page 30: Gmo the value vs growth dilemma

Value versus growth: 1927-2008

30

-60

-40

-20

0

20

40

60

19

27

19

29

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Mkt-RF HML

Great Depression – I (1929)

Great Depression – II (1937) Oil shock – I (1973)

Oil shock – II (1981)

End of tech. bubble (2000)

Great Recession - (2008)

Annual market returns in excess of the one year treasury bill rate and the annual returns on a zero investment portfolio that is

long value stocks and short growth. 1927-2008. Source: Ken French database

Page 31: Gmo the value vs growth dilemma

The value premium: Is it risk?

-40

-30

-20

-10

0

10

20

30

40

19

26

07

19

26

10

19

27

01

19

27

04

19

27

07

19

27

10

19

28

01

19

28

04

19

28

07

19

28

10

19

29

01

19

29

04

19

29

07

19

29

10

19

30

01

19

30

04

19

30

07

19

30

10

19

31

01

19

31

04

19

31

07

19

31

10

19

32

01

19

32

04

19

32

07

19

32

10

19

33

01

19

33

04

19

33

07

19

33

10

19

34

01

19

34

04

19

34

07

19

34

10

19

35

01

19

35

04

19

35

07

19

35

10

19

36

01

19

36

04

19

36

07

19

36

10

19

37

01

19

37

04

19

37

07

19

37

10

19

38

01

19

38

04

19

38

07

19

38

10

19

39

01

19

39

04

19

39

07

19

39

10

Mkt-RF

Monthly market returns in excess of the one month treasury bill – 1926-07 – 1939-12.

Source: Ken French database.

Page 32: Gmo the value vs growth dilemma

The value premium: Is it risk?

-40

-30

-20

-10

0

10

20

30

40

19

26

07

19

26

10

19

27

01

19

27

04

19

27

07

19

27

10

19

28

01

19

28

04

19

28

07

19

28

10

19

29

01

19

29

04

19

29

07

19

29

10

19

30

01

19

30

04

19

30

07

19

30

10

19

31

01

19

31

04

19

31

07

19

31

10

19

32

01

19

32

04

19

32

07

19

32

10

19

33

01

19

33

04

19

33

07

19

33

10

19

34

01

19

34

04

19

34

07

19

34

10

19

35

01

19

35

04

19

35

07

19

35

10

19

36

01

19

36

04

19

36

07

19

36

10

19

37

01

19

37

04

19

37

07

19

37

10

19

38

01

19

38

04

19

38

07

19

38

10

19

39

01

19

39

04

19

39

07

19

39

10

Mkt-RF

Monthly market returns in excess of the one month treasury bill – 1926-07 – 1939-12.

Source: Ken French database.

1929-10 1931-09

1932-05

1938-03

Page 33: Gmo the value vs growth dilemma

The value premium: Is it risk?

-40

-30

-20

-10

0

10

20

30

40

19

26

07

19

26

10

19

27

01

19

27

04

19

27

07

19

27

10

19

28

01

19

28

04

19

28

07

19

28

10

19

29

01

19

29

04

19

29

07

19

29

10

19

30

01

19

30

04

19

30

07

19

30

10

19

31

01

19

31

04

19

31

07

19

31

10

19

32

01

19

32

04

19

32

07

19

32

10

19

33

01

19

33

04

19

33

07

19

33

10

19

34

01

19

34

04

19

34

07

19

34

10

19

35

01

19

35

04

19

35

07

19

35

10

19

36

01

19

36

04

19

36

07

19

36

10

19

37

01

19

37

04

19

37

07

19

37

10

19

38

01

19

38

04

19

38

07

19

38

10

19

39

01

19

39

04

19

39

07

19

39

10

Mkt-RF Value-Growth

Monthly market returns in excess of the one month treasury bill and the monthly returns

on a zero investment portfolio that is long value stocks and short growth. 1926-07 – 1939-

12. Source: Ken French database

1929-10 1931-09

1932-05

1938-03

Page 34: Gmo the value vs growth dilemma

The value premium: Is it risk?

-20

-15

-10

-5

0

5

10

15

20

03

01

20

03

03

20

03

05

20

03

07

20

03

09

20

03

11

20

04

01

20

04

03

20

04

05

20

04

07

20

04

09

20

04

11

20

05

01

20

05

03

20

05

05

20

05

07

20

05

09

20

05

11

20

06

01

20

06

03

20

06

05

20

06

07

20

06

09

20

06

11

20

07

01

20

07

03

20

07

05

20

07

07

20

07

09

20

07

11

20

08

01

20

08

03

20

08

05

20

08

07

20

08

09

20

08

11

20

09

01

20

09

03

20

09

05

20

09

07

20

09

09

Mkt-RF

Monthly market returns in excess of the one month treasury bill – 2003-01 –2009-10.

Source: Ken French database.

2008-10

2008-09

Page 35: Gmo the value vs growth dilemma

The value premium: Is it risk?

-20

-15

-10

-5

0

5

10

15

20

03

01

20

03

03

20

03

05

20

03

07

20

03

09

20

03

11

20

04

01

20

04

03

20

04

05

20

04

07

20

04

09

20

04

11

20

05

01

20

05

03

20

05

05

20

05

07

20

05

09

20

05

11

20

06

01

20

06

03

20

06

05

20

06

07

20

06

09

20

06

11

20

07

01

20

07

03

20

07

05

20

07

07

20

07

09

20

07

11

20

08

01

20

08

03

20

08

05

20

08

07

20

08

09

20

08

11

20

09

01

20

09

03

20

09

05

20

09

07

20

09

09

Mkt-RF Value-Growth

2008-10

2008-09

Monthly market returns in excess of the one month treasury bill and the monthly returns

on a zero investment portfolio that is long value stocks and short growth. 2003-01 –2009-10.

Source: Ken French database

2008-09

Page 36: Gmo the value vs growth dilemma

The value premium: Is it risk?

-30

-20

-10

0

10

20

30

40

50

19

93

19

94

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

20

06

Mkt-RF

Annual market returns in excess of the one year treasury bill. 1993-2006. Source: Ken

French database

Page 37: Gmo the value vs growth dilemma

The value premium: Is it risk?

-30

-20

-10

0

10

20

30

40

50

19

93

19

94

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

20

06

Mkt-RF Value-Growth

Annual market returns in excess of the one year treasury bill rate and the annual returns

on a zero investment portfolio that is long value stocks and short growth. 1993-2006.

Source: Ken French database

Page 38: Gmo the value vs growth dilemma

The value premium: Is it risk?

38

-30

-20

-10

0

10

20

30

40

50

19

95

19

96

19

97

19

98

19

99

20

00

20

01

20

02

20

03

20

04

20

05

Growth Value

Annual market returns of a value weighted portfolio of the top (value) and bottom (growth) 20% of stocks sorted by BE/ME .

1993-2006. Source: Ken French database

Page 39: Gmo the value vs growth dilemma

The value premium: Is it risk?

• Thus it looks that value stocks do relatively better

than growth stocks in bad (market) times (though not

always!):

- The Great Depression first shock of 1929

- The oil shocks of 1970s and early 1980s

- The end of the technology bubble.

• And worse than growth during the tech bubble.

• If value stocks were riskier than growth they should

be doing worse in bad times, as measured by the

market, but they don’t seem to, at least in some

significant episodes.

39

Page 40: Gmo the value vs growth dilemma

The value premium: Is it risk?

• Before we turn to a potential behavioral explanation

it is worth going deeper into the issue of whether

value was always less risky than growth (according to

the CAPM!)

• For this we run the following exercise we estimate

betas using a trailing five year window with data

starting in 1926-07 all the way up to 2009-09.

• As before we use the market model and we estimate

betas by running time series regressions of excess

returns for the BE/ME portfolios on market excess

returns.

40

Page 41: Gmo the value vs growth dilemma

The value premium: Is it risk?

41

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

2.2

2.4

19

30

07

19

31

12

19

33

05

19

34

10

19

36

03

19

37

08

19

39

01

19

40

06

19

41

11

19

43

04

19

44

09

19

46

02

19

47

07

19

48

12

19

50

05

19

51

10

19

53

03

19

54

08

19

56

01

19

57

06

19

58

11

19

60

04

19

61

09

19

63

02

19

64

07

19

65

12

19

67

05

19

68

10

19

70

03

19

71

08

19

73

01

19

74

06

19

75

11

19

77

04

19

78

09

19

80

02

19

81

07

19

82

12

19

84

05

19

85

10

19

87

03

19

88

08

19

90

01

19

91

06

19

92

11

19

94

04

19

95

09

19

97

02

19

98

07

19

99

12

20

01

05

20

02

10

20

04

03

20

05

08

20

07

01

20

08

06

Growth

Monthly time series of market betas for the value and growth portfolios, defined as the top and bottom

decile, respectively, of the book-to-market sorted portfolios for the sample 1926-07 to 2009-09. The betas

are estimated using a rolling five year window. The monthly returns are from Ken French’s data base.

Page 42: Gmo the value vs growth dilemma

The value premium: Is it risk?

42

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

2.2

2.4

19

30

07

19

31

12

19

33

05

19

34

10

19

36

03

19

37

08

19

39

01

19

40

06

19

41

11

19

43

04

19

44

09

19

46

02

19

47

07

19

48

12

19

50

05

19

51

10

19

53

03

19

54

08

19

56

01

19

57

06

19

58

11

19

60

04

19

61

09

19

63

02

19

64

07

19

65

12

19

67

05

19

68

10

19

70

03

19

71

08

19

73

01

19

74

06

19

75

11

19

77

04

19

78

09

19

80

02

19

81

07

19

82

12

19

84

05

19

85

10

19

87

03

19

88

08

19

90

01

19

91

06

19

92

11

19

94

04

19

95

09

19

97

02

19

98

07

19

99

12

20

01

05

20

02

10

20

04

03

20

05

08

20

07

01

20

08

06

Growth Value

Monthly time series of market betas for the value and growth portfolios, defined as the top and bottom

decile, respectively, of the book-to-market sorted portfolios for the sample 1926-07 to 2009-09. The betas

are estimated using a rolling five year window. The monthly returns are from Ken French’s data base.

Page 43: Gmo the value vs growth dilemma

The value premium: A behavioral view

• As we just saw, a “risk story” faces challenges in

addressing the value premium.

• One of the biggest divide in finance academic circles:

- Rational: The value premium is a compensation for risk; we

just simply don’t observe the proper measure of risk (and

the CAPM βs do not describe risk).

- Behavioral: The value premium is a reflection of systematic

underpricing of value stocks by investors.

• We study next the behavioral story.

43

Page 44: Gmo the value vs growth dilemma

The value premium: A behavioral view

• Lakonishok, Shleifer and Vishny (JF, 1994) argue that

the value premium arises because:

- Value portfolios are comprised of stocks that have

“underperformed” recently according to some metrics such

as returns and earnings and

- that investors extrapolate this past performance into the

future and thus expect equally dismal results.

- As a result they stay away from these distressed stocks

which fall in price relative to fundamentals, such as a book,

and thus the higher returns when performance surprises on

the positive side.

44

Page 45: Gmo the value vs growth dilemma

The value premium: A behavioral view

• This logic is an example of the representative

heuristic (Tversky and Kahneman, 1974), the

tendency of individuals to identify the an uncertain

event or a sample by the degree to which is similar to

the parent population.

• To quote Benjamin Graham:

“[Strong past returns] created a natural satisfaction on Wall

Street with such fine achievements, and a quite illogical and

dangerous conviction that equally marvelous results could

be expected for common stocks in the future. Few people

seem to have been bothered by the thought that the very

extent of the rise might indicate that it had been overdone.”

The Intelligent Investor, Revised Ed 1984, pp. 67-69.45

Page 46: Gmo the value vs growth dilemma

The value premium: A behavioral view

• LSV offer some striking evidence of their thesis.

• Take the same extreme value and growth portfolios

that we constructed above and calculate some

measure of past and future performance for these

portfolios:

- Earnings

- Sales

- Cash flows

46

Page 47: Gmo the value vs growth dilemma

The value premium: A behavioral view

Growth Value

AEG(-5,0) .309 -.274

AEG(0,5) .050 .436

AEG(2,5) .070 .215

ACG(-5,0) .217 -.013

ACG(0,5) .127 .070

ACG(2,5) .086 .111

ASG(-5,0) .091 .030

ASG(0,5) .062 .020

ASG(2,5) .059 .023

47

AEG(i,j) is the geometric average growth rate of earnings for the portfolio from year i to year j.

ACG(i,j) and ASG(i,j) are defined analagously for cash-flow and sales respectively.

Source: J. Lakonishok,A. Shleifer and R.Vishny. Journal of Finance, Dec. 1994,TableV.

Page 48: Gmo the value vs growth dilemma

The value premium: A behavioral view

Growth Value

AEG(-5,0) .309 -.274

AEG(0,5) .050 .436

AEG(2,5) .070 .215

ACG(-5,0) .217 -.013

ACG(0,5) .127 .070

ACG(2,5) .086 .111

ASG(-5,0) .091 .030

ASG(0,5) .062 .020

ASG(2,5) .059 .023

48

AEG(i,j) is the geometric average growth rate of earnings for the portfolio from year i to year j.

ACG(i,j) and ASG(i,j) are defined analagously for cash-flow and sales respectively.

Source: J. Lakonishok,A. Shleifer and R.Vishny. Journal of Finance, Dec. 1994,TableV.

Page 49: Gmo the value vs growth dilemma

The value premium: A behavioral view

• Thus it seems that past earnings growth fostered

pessimism on these stocks which led to low prices

and realized low returns

• These stocks thus get classified as value.

• After that, these same stocks surprise on the upside

and thus the larger return after being classified as

value.

• This behavioral story fits with a particular

psychological bias which is that of extrapolation

49

Page 50: Gmo the value vs growth dilemma

Momentum

• Value strategies are perhaps the most famous of

sorts, but the strategy to uncover sources of average

excess returns are always the same:

- Sort stocks along your favorite characteristic.

- Form portfolios, say decile portfolios, and track their

returns over a particular period.

- Reform the portfolios at a frequency of your choice (in the

case of book-to-market sorted portfolios the standard rule

is to resort portfolios after one year.)

- Compute average excess returns across these portfolios

and test whether whatever cross sectional dispersion in

average returns can be explained by some measure of risk.

50

Page 51: Gmo the value vs growth dilemma

Momentum

• Momentum portfolios are those where the sort is

driven by past returns:

- Each month, say, we place stocks in portfolios according to

their performance in the last year.

- We then compute the returns of the so formed portfolios

for the following month.

• The idea behind momentum is easy enough to explain

- Stocks that did well in the recent past are going to keep

doing well, whereas those that did poorly are going to

underperform.

51

Page 52: Gmo the value vs growth dilemma

Momentum

Low 2 3 4 5 6 7 8 9 High

Avge.

Returns

(%)

monthly

0.33 0.70 0.71 0.85 0.85 0.92 1.00 1.12 1.19 1.52

52

Monthly returns, in percentages, of ten portfolios sorted on realized returns over the previous year.

Thus the returns in month t, corresponds to the portfolio formed at the end of month t-1, based on

realized returns from t-1 to t-13. 1927-01 to 2009-09. Source: Ken French data base

•Notice thus the portfolio of past winners outperforms

the portfolio of past losers by more than a percentage

point a month!

Page 53: Gmo the value vs growth dilemma

Momentum

• Momentum has deep implications for the value

investor.

- Value investors focus on “cheap and ugly” stocks.

- If these have become such over the last year, it means that

one can expect them to remain so and to keep

underperforming in the short run.

• Finally, notice that it is difficult to conceive of a risk

based story that can account for the dispersion in

average returns across momentum sorted portfolios

as the frequency is much higher than that at which

macroeconomic news occur.

53

Page 54: Gmo the value vs growth dilemma

Momentum

54

-60

-40

-20

0

20

40

60

80

19

27

19

29

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Mom Mkt-Rf

Annual returns for the momentum factor and market excess return; 1927-2009; Source: Ken French data base. The construction of the Momentum Factor is due to Ken

French. It is based on “six value-weight portfolios formed on size and prior (2-12) returns to construct Mom. The portfolios, which are formed monthly, are the

intersections of 2 portfolios formed on size (market equity, ME) and 3 portfolios formed on prior (2-12) return. The monthly size breakpoint is the median NYSE

market equity. The monthly prior (2-12) return breakpoints are the 30th and 70th NYSE percentiles. Mom is the average return on the two high prior return portfolios

minus the average return on the two low prior return portfolios: Mom = 1/2 (Small High + Big High) - 1/2(Small Low + Big Low).

Page 55: Gmo the value vs growth dilemma

Momentum

• There are many possible explanations for momentum:

- Conservatism bias: Investors underreact to new

information, effectively underweighting new data, and this

gives rise to momentum profits.

- There is also evidence that, at least in the past, mutual fund

managers tended to buy past winners and sell past losers

creating the conditions for the momentum effect to arise.

- There are explanations also based on self-attribution bias.

For instance, negative news about stocks are attributed to

“bad luck” rather than poor skills and thus mangers don’t

liquidate their position delaying the full incorporations of

news in prices.

55

Page 56: Gmo the value vs growth dilemma

Long term reversals

• Momentum is the observation that stocks that have

done well in the recent past (last year) do well in the

near future (generally, 3 months to a year) whereas

stocks that have done poorly keep underperforming.

• Momentum can lead to overvaluation but if this is the

case we should observe some long term reversal. Is this

the case?

- The answer is yes: When we sort stocks based on the

performance between one and five years there is substantial

evidence that bad performers tend to perform better

whereas the opposite is true for winners.

56

Page 57: Gmo the value vs growth dilemma

Long term reversals

• To check this we now sort stocks on a monthly basis

based on their performance between one and five

year into ten portfolios. Then we compute their

monthly returns:

57

Low 2 3 4 5 6 7 8 9 High

Avge.

Monthly

returns

(%)

1.47 1.26 1.24 1.04 1.10 0.99 1.02 1.02 0.87 0.87

Average monthly returns, in percentages, of ten portfolios sorted at the end of month t-1 based on

returns between months t-13 and month t-60. 1931-01 to 2009-09. The stocks are all stocks

In NYSE, Nasdaq and AMEX. Source: Ken French data base

Page 58: Gmo the value vs growth dilemma

Long term reversals

58

-50

-30

-10

10

30

50

70

90

19

31

19

33

19

35

19

37

19

39

19

41

19

43

19

45

19

47

19

49

19

51

19

53

19

55

19

57

19

59

19

61

19

63

19

65

19

67

19

69

19

71

19

73

19

75

19

77

19

79

19

81

19

83

19

85

19

87

19

89

19

91

19

93

19

95

19

97

19

99

20

01

20

03

20

05

20

07

Long Term Reversal Factor Mkt-Rf

Annual returns of the long term reversal factor versus the market excess return over the one year treasury bill rate.

1931 to 2008. Source: Ken French data base, which should be consulted for the construction of the factor

Page 59: Gmo the value vs growth dilemma

THE MARKET

59

Page 60: Gmo the value vs growth dilemma

Some thoughts on the market

• Value investors are reluctant to give advice regarding

the timing of Mr. Market, being aware of its

intemperate, capricious and childish ways!

• Still, one should not make the mistake of ignoring the

vagaries of the market.

• It is important to try to make sense of its gyrations.

• Next we try to cover briefly where we are and some

general lessons for the value investor regarding the

market outlook.

60

Page 61: Gmo the value vs growth dilemma

Some thoughts on the market

61

0

200

400

600

800

1000

1200

1400

1600

1800

2000

1870 1890 1910 1930 1950 1970 1990 2010

Rea

l S

&P

50

0 S

tock

Pri

ce I

nd

ex

Year

Price

Real S&P Stock Price Index and Composite Earnings. Monthly 1871-01 to 2010-01 (Jan. 13)

Source: Robert Shiller

Page 62: Gmo the value vs growth dilemma

Some thoughts on the market

62

0

50

100

150

200

250

300

350

400

450

0

200

400

600

800

1000

1200

1400

1600

1800

2000

1870 1890 1910 1930 1950 1970 1990 2010

Rea

l S

&P

Co

mp

osi

te E

arn

ing

s

Rea

l S

&P

50

0 S

tock

Pri

ce I

nd

ex

Year

Price

Earnings

Real S&P Stock Price Index and Composite Earnings. Monthly 1871-01 to 2010-01 (Jan. 13)

Source: Robert Shiller

Page 63: Gmo the value vs growth dilemma

Some thoughts on the market

63

0

5

10

15

20

25

30

35

40

45

18

81

.01

18

83

.05

18

85

.09

18

88

.01

18

90

.05

18

92

.09

18

95

.01

18

97

.05

18

99

.09

19

02

.01

19

04

.05

19

06

.09

19

09

.01

19

11

.05

19

13

.09

19

16

.01

19

18

.05

19

20

.09

19

23

.01

19

25

.05

19

27

.09

19

30

.01

19

32

.05

19

34

.09

19

37

.01

19

39

.05

19

41

.09

19

44

.01

19

46

.05

19

48

.09

19

51

.01

19

53

.05

19

55

.09

19

58

.01

19

60

.05

19

62

.09

19

65

.01

19

67

.05

19

69

.09

19

72

.01

19

74

.05

19

76

.09

19

79

.01

19

81

.05

19

83

.09

19

86

.01

19

88

.05

19

90

.09

19

93

.01

19

95

.05

19

97

.09

20

00

.01

20

02

.05

20

04

.09

20

07

.01

20

09

.05

Price to (10 year smoothed) earnings ratio of S&P Index – 1881-01 to 2010-01. Source: Robert Shiller

Page 64: Gmo the value vs growth dilemma

Some thoughts on the market

• More recently, the market has rallied dramatically

since its low in March 2009.

• This has been very painful for many investors (value

or not) who have remained skeptical about the

sources and sustainability of the recovery.

- In particular, the recovery seems to be fueled by a world

wide expansion of the monetary base.

• Before we turn to this rally let’s consider one

previous rally in times that were economically

challenging as well.

64

Page 65: Gmo the value vs growth dilemma

Some thoughts on the market

65

• S&P composite 12/28-04/30

• One dollar invested in the

index at the peak, in Sept.

1929, becomes only 71cents

in November 1929

• One dollar (re)invested at

the (local) bottom of

November 1929 becomes

$1.52 in April 1930.

• The plot is the price and one

has to account for dividends,

which are also reinvested.

• What happened afterwards?

20.00

22.00

24.00

26.00

28.00

30.00

32.00

19

28

.12

19

29

.01

19

29

.02

19

29

.03

19

29

.04

19

29

.05

19

29

.06

19

29

.07

19

29

.08

19

29

.09

19

29

.1

19

29

.11

19

29

.12

19

30

.01

19

30

.02

19

30

.03

19

30

.04

S&P composite price. Monthly. 12/28-04/30. Source: Robert Shiller

-30%

+50%

Page 66: Gmo the value vs growth dilemma

Some thoughts on the market

66

0.00

5.00

10.00

15.00

20.00

25.00

30.00

35.00

40.00

45.00

50.00

19

29

.01

19

29

.07

19

30

.01

19

30

.07

19

31

.01

19

31

.07

19

32

.01

19

32

.07

19

33

.01

19

33

.07

19

34

.01

19

34

.07

19

35

.01

19

35

.07

19

36

.01

19

36

.07

19

37

.01

19

37

.07

19

38

.01

19

38

.07

19

39

.01

19

39

.07

19

40

.01

19

40

.07

19

41

.01

19

41

.07

19

42

.01

19

42

.07

19

43

.01

19

43

.07

19

44

.01

19

44

.07

19

45

.01

19

45

.07

19

46

.01

19

46

.07

19

47

.01

19

47

.07

19

48

.01

19

48

.07

19

49

.01

19

49

.07

19

50

.01

19

50

.07

19

51

.01

19

51

.07

19

52

.01

19

52

.07

19

53

.01

19

53

.07

19

54

.01

19

54

.07

19

55

.01

19

55

.07

S&P composite price. Monthly. 1/29-12/55. Source: Robert Shiller

Page 67: Gmo the value vs growth dilemma

Some thoughts on the market

67

0.00

5.00

10.00

15.00

20.00

25.00

30.00

35.00

40.00

45.00

50.00

19

29

.01

19

29

.07

19

30

.01

19

30

.07

19

31

.01

19

31

.07

19

32

.01

19

32

.07

19

33

.01

19

33

.07

19

34

.01

19

34

.07

19

35

.01

19

35

.07

19

36

.01

19

36

.07

19

37

.01

19

37

.07

19

38

.01

19

38

.07

19

39

.01

19

39

.07

19

40

.01

19

40

.07

19

41

.01

19

41

.07

19

42

.01

19

42

.07

19

43

.01

19

43

.07

19

44

.01

19

44

.07

19

45

.01

19

45

.07

19

46

.01

19

46

.07

19

47

.01

19

47

.07

19

48

.01

19

48

.07

19

49

.01

19

49

.07

19

50

.01

19

50

.07

19

51

.01

19

51

.07

19

52

.01

19

52

.07

19

53

.01

19

53

.07

19

54

.01

19

54

.07

19

55

.01

19

55

.07

S&P composite price. Monthly. 1/29-12/55. Source: Robert Shiller

This is the episode in the previous plot

Page 68: Gmo the value vs growth dilemma

Some thoughts on the market

68

0.00

5.00

10.00

15.00

20.00

25.00

30.00

35.00

40.00

45.00

50.00

19

29

.01

19

29

.07

19

30

.01

19

30

.07

19

31

.01

19

31

.07

19

32

.01

19

32

.07

19

33

.01

19

33

.07

19

34

.01

19

34

.07

19

35

.01

19

35

.07

19

36

.01

19

36

.07

19

37

.01

19

37

.07

19

38

.01

19

38

.07

19

39

.01

19

39

.07

19

40

.01

19

40

.07

19

41

.01

19

41

.07

19

42

.01

19

42

.07

19

43

.01

19

43

.07

19

44

.01

19

44

.07

19

45

.01

19

45

.07

19

46

.01

19

46

.07

19

47

.01

19

47

.07

19

48

.01

19

48

.07

19

49

.01

19

49

.07

19

50

.01

19

50

.07

19

51

.01

19

51

.07

19

52

.01

19

52

.07

19

53

.01

19

53

.07

19

54

.01

19

54

.07

19

55

.01

19

55

.07

S&P composite price. Monthly. 1/29-12/55. Source: Robert Shiller

August 1929: 31.30 September 1954: 31.45

Page 69: Gmo the value vs growth dilemma

Some thoughts on the market

• What fueled the impressive

rally between November

1929 and April 1930?

• Nothing: Economic news

were dismal and in fact the

economy was in for a

massive downturn.

• No wonder the market

resumed its downfall

afterwards.

• It took 25 years to cross the

level of August 1929 again.

69

-15.0

-10.0

-5.0

0.0

5.0

10.0

15.0

20.0

19

30

-01

-01

19

31

-01

-01

19

32

-01

-01

19

33

-01

-01

19

34

-01

-01

19

35

-01

-01

19

36

-01

-01

19

37

-01

-01

19

38

-01

-01

19

39

-01

-01

19

40

-01

-01

19

41

-01

-01

19

42

-01

-01

19

43

-01

-01

19

44

-01

-01

19

45

-01

-01

Real GNP growth –percent change from a year ago– 1930 to 1945. Source: St. Louis Fed

Page 70: Gmo the value vs growth dilemma

Some thoughts on the market

70

700

800

900

1000

1100

1200

1300

1400

1500

1600

20

07

.01

20

07

.03

20

07

.05

20

07

.07

20

07

.09

20

07

.11

20

08

.01

20

08

.03

20

08

.05

20

08

.07

20

08

.09

20

08

.11

20

09

.01

20

09

.03

20

09

.05

20

09

.07

20

09

.09

20

09

.11

20

10

.01

20.00

22.00

24.00

26.00

28.00

30.00

32.00

19

28

.12

19

29

.01

19

29

.02

19

29

.03

19

29

.04

19

29

.05

19

29

.06

19

29

.07

19

29

.08

19

29

.09

19

29

.1

19

29

.11

19

29

.12

19

30

.01

19

30

.02

19

30

.03

19

30

.04

S&P 500 index during two big market corrections: 2007-01 to 2010-01 & 1928-12 to 1930-04. Source: Robert Shiller

Page 71: Gmo the value vs growth dilemma

Some thoughts on the market

71

700

800

900

1000

1100

1200

1300

1400

1500

1600

20

07

.01

20

07

.03

20

07

.05

20

07

.07

20

07

.09

20

07

.11

20

08

.01

20

08

.03

20

08

.05

20

08

.07

20

08

.09

20

08

.11

20

09

.01

20

09

.03

20

09

.05

20

09

.07

20

09

.09

20

09

.11

20

10

.01

• The market has rallied

dramatically since the trough

in March 2009. What is

different?

- Some of it real: No Great

Depression – II

- Main difference: Policy

response

- Fiscal

- Monetary:

• Low rates and promises of

low rates

• Money base expansion

Page 72: Gmo the value vs growth dilemma

Some thoughts on the market

72

0

200

400

600

800

1000

1200

1400

1600

1800

0

200000

400000

600000

800000

1000000

1200000

1400000

1600000

1800000

20

07

-01

-03

20

07

-01

-24

20

07

-02

-14

20

07

-03

-07

20

07

-03

-28

20

07

-04

-18

20

07

-05

-09

20

07

-05

-30

20

07

-06

-20

20

07

-07

-11

20

07

-08

-01

20

07

-08

-22

20

07

-09

-12

20

07

-10

-03

20

07

-10

-24

20

07

-11

-14

20

07

-12

-05

20

07

-12

-26

20

08

-01

-16

20

08

-02

-06

20

08

-02

-27

20

08

-03

-19

20

08

-04

-09

20

08

-04

-30

20

08

-05

-21

20

08

-06

-11

20

08

-07

-02

20

08

-07

-23

20

08

-08

-13

20

08

-09

-03

20

08

-09

-24

20

08

-10

-15

20

08

-11

-05

20

08

-11

-26

20

08

-12

-17

20

09

-01

-07

20

09

-01

-28

20

09

-02

-18

20

09

-03

-11

20

09

-04

-01

20

09

-04

-22

20

09

-05

-13

20

09

-06

-03

20

09

-06

-24

20

09

-07

-15

20

09

-08

-05

20

09

-08

-26

20

09

-09

-16

Securities held outright S&P500

Securities (Treasuries, MBS, and Agency Debt) held by the Federal Reserve (in millions) vs. the S&P500; weekly; 2007-01-03 to 2009-09-16

Page 73: Gmo the value vs growth dilemma

Some thoughts on the market

• Whether the recovery justifies the prices is difficult to

say but there are reasons to question the recent rally.

• In the words of Jeremy Grantham:- “Riding a bubble is a guilty pleasure totally denied to value managers

who typically pay a high price to the God of Investment Discipline …”

- “Risk taking has come roaring back. Value, it must be admitted, is

seldom a powerful force in the short term. The Fed’s weapons of low

rates, plenty of money and the promise of future help if necessary

seems stronger than value over a few quarters. And the forces of

herding and momentum are also helping to push prices up, with the

market apparently quite unrepentant of recent crimes and willing to be

silly again. ” Jeremy Grantham, Just Deserts and Markets Being Silly Again, GMO Quarterly Letter, October 2009

73